DESCRIPTION
- Acute glomerulonephritis (AGN) is acute inflammatory damage to glomerulus, associated with:
- Abrupt onset of hematuria with or without RBC casts
- Acute renal failure manifested by edema, hypertension, azotemia, decline in urine output
- Variable proteinuria
- Active urine sediment (RBC casts)
- Exact mechanism of AGN unclear:
- Combination of autoimmune reactivity to specific antigens at renal glomeruli
- Characterized by crescent formation secondary to nonspecific injury at the glomerular wall
ETIOLOGY
- Poststreptococcal glomerulonephritis (PSGN):
- A postinfectious cause of acute nephritic syndrome, resulting from group A β-hemolytic streptococci
- Considered a nonsuppurative complication (antibiotic treatment does not prevent this complication)
- Occurs when immune complexes create hump-shaped subepithelial deposits in renal glomeruli
- Most commonly affects patients between ages 3 and 15 yr but can occur at any age
- Incidence of nephritis is 5–10% after pharyngitis and 25% after skin infections.
- Consider PSGN in the setting of new-onset proteinuria, RBC casts, edema, and any recent infection.
- Latent period between infection and onset of nephritis helps differentiate between PSGN and IgA nephropathy:
- 1–3 wk in pharyngeal infection
- 2–4 wk in cutaneous infection
- Renal biopsy is usually not necessary for diagnosis.
- Low complement (C3) for 6–8 wk
- Can progress to severe renal failure if underlying infection goes untreated
- Prognosis:
- Excellent; >95% recover spontaneously with normalization of renal function within 6–8 wk, even with dialysis.
- Hematuria usually resolves in 3–6 mo.
- Transient nephrotic phase in 20% of patients during resolution of illness
- End-stage renal disease occurs <5%
- Rapidly progressive glomerulonephritis (RPGN) is rare, occurring in <1% cases.
- Most cases resolve spontaneously with no long-term sequelae.
- Other infectious sources of glomerulonephritis (GN):
- Sepsis, pneumonia, endocarditis, viruses, HIV
- Pulmonary, intra-abdominal, or cutaneous infections
- Syphilis, leprosy, schistosomiasis, and malaria
- Goal: Treat underlying infection.
- Hepatitis virus–related glomerular disease:
- Can present with either nephritic or nephrotic symptoms
- Causes membranoproliferative GN
- Complements remain low indefinitely (compared to PSGN)
- Noninfectious causes of GN (due to immune complex formation):
- Systematic lupus erythematosus, Henoch–Schönlein purpura, vasculitis, Wegener granulomatosis
- Goodpasture syndrome
- IgA nephropathy (IgA-N)
- Most common cause of AGN (>25%) worldwide
- Antibody–antigen causes immune complex deposition of IgA and C3
- Complement levels are usually normal.
- IgA-N has different presentations:
- Gross hematuria following upper respiratory infection (URI)
- Microscopic hematuria with proteinuria
- Hematuria during viral illness or after exercise
- Prognosis is related to serum creatinine, BP, and proteinuria.
- 50% of patients with proteinuria may develop progressive renal disease.
- ACE inhibitors or angiotensin-receptor blockers (ARBs) may help
- RPGN:
- Certain patients with AGN may progress rapidly to renal failure.
- Hallmarks are crescents on renal biopsy.
- Hereditary nephritis
DIAGNOSIS
SIGNS AND SYMPTOMS
- Hematuria:
- Abrupt onset gross hematuria in 30–40% (coffee- or cola-colored urine)
- Edema:
- Periorbital edema
- Generalized edema more common in infants and children
- Infectious source or recent infection: Upper respiratory tract or skin common, e.g., PSGN
- Symptoms of congestive heart failure:
- 40% occurrence in patients >60 yr
- Rare in children
- Arthritis, arthralgias, and various skin rashes: PSGN, systemic disease
- Nonspecific manifestations:
- Malaise
- Weakness
- Anorexia
- Nausea/vomiting
History
- Recent URI or skin or other infection
- Change in urine color
Physical-Exam
ESSENTIAL WORKUP
Urinalysis with sediment evaluation to detect:
- RBCs, proteinuria, and RBC casts
- RBC casts are diagnostic of an active glomerular inflammation.
DIAGNOSIS TESTS & NTERPRETATION
Lab
- CBC:
- Anemia (seen in more chronic cases of GN or other systemic disease)
- Acute leukocytosis (may suggest infectious process)
- Basic metabolic panel:
- Assess baseline renal function
- Check for electrolyte abnormalities
- GFR will be normal or nearly normal
- Urinalysis:
- Serum albumin
- Cultures (throat, skin, urine, blood):
- As clinically suspected for infectious source
- Streptozyme
- Serum complement level (C3): Decreased in infectious endocarditis, shunt nephritis, and PSGN
- Streptococcal antibodies:
- Antistreptolysin (ASO), antistreptokinase (ASK), antideoxyribonuclease B (ADNase B), antinicotinyl adenine dinucleotidase (ANADase), and antihyaluronidase (AH)
- ASO more reactive in pharyngeal infections
- ADNase B, ANADase, and AH more reactive in cutaneous infections
- ASK elevated in recent hemolytic Streptococcus infections
- Titers do not correlate with prognosis of disease
- Urine osmolality, sodium, creatinine
- 24-hr urine collection:
- Proteinuria initially present in 5% of children, 20% of adults with PSGN
Imaging
- Renal ultrasound: Kidney size abnormality
- Chest radiograph: Cardiomegaly, pulmonary edema, infection
Diagnostic Procedures/Surgery
Renal biopsy:
- Generally not done for PSGN, as symptoms typically resolve after a brief illness
- Recommended if atypical features of PSGN, persistently abnormal complement levels, persistent hypertension, and proteinuria >3 g/d
- Facilitates diagnosis for other causes of nephritis
DIFFERENTIAL DIAGNOSIS
- (See “Glomerulonephritis” for further information on types of GN)
- Renal:
- Primary glomerular disease
- Systemic:
- Goodpasture syndrome
- Vasculitis
- Henoch–Schönlein purpura
- Other (rare):
- Hemolytic-uremic syndrome
- Thrombotic thrombocytopenic purpura
- Acute hypersensitivity interstitial nephritis
- Serum sickness
TREATMENT
PRE HOSPITAL
Support ABCs
INITIAL STABILIZATION/THERAPY
ABCs
ED TREATMENT/PROCEDURES
- Antibiotics for streptococcal infection:
- Penicillin (erythromycin, if penicillin allergic)
- Restrict salt and fluid intake
- Administer loop diuretics (furosemide)
- Restore urine flow in oliguric patients:
- Treat pulmonary edema:
- Oxygen
- Morphine
- Loop diuretics
- Stabilize BP to decrease proteinuria, retard progression of GN:
- ACEIs, ARBs
- Hypertensive emergency: Nitroprusside or other titratable antihypertensive medication
- Hemodialysis for:
- Severe hyperkalemia
- Fluid overload
- Uremia
- Severe acidosis
- Correct electrolyte abnormalities
MEDICATION
- Erythromycin: 250–500 mg (peds: 30–50 mg/kg/d) PO q6h for 7–10 days
- Furosemide: 20–80 mg (peds: 1–6 mg/kg) PO daily/BID
- Lisinopril (ACEI): 10–40 mg (peds: >6 yr: 0.07 mg/kg) PO daily
- Losartan (ARB): 25–100 mg (peds: >6 yr: 0.7 mg/kg) PO daily
- Mannitol: 12.5–100 g (peds: 0.25–0.5 g/kg) IV:
- May use single or repeat dosing; consider test dosing 1st.
- Morphine sulfate: 0.1 mg/kg/dose IV q4h
- Nitroprusside: 0.3–4 μg/kg/min IV
- Titrate to goal mean arterial pressure for hypertensive emergency.
- Penicillin:
- Benzathine penicillin: 1.2 million U (peds: 0.3–0.9 million U, based on weight) IM as single dose
- Penicillin VK: 250–500 mg (peds: <12 yr 25–50 mg/kg/d) PO q6–8h for 10 days
- Other agents, including fish oil (ω-3 fatty acids for anti-inflammatory effects) and immunosuppressive agents (glucocorticoids, cyclophosphamide), may be used in consultation with specialists.
FOLLOW-UP
DISPOSITION
Admission Criteria
- Evidence of infectious cause for GN
- Oliguria, anuria
- Uremia
- Elevated creatinine
- Edema
- Electrolyte abnormalities
- Severe hypertension
- CHF